Bacillus Calmette-Guérin (BCG), a live attenuated strain of Mycobacterium bovis, is currently the only agent approved by the US Food and Drug Administration for primary therapy of carcinoma in situ (CIS; see image below) of the bladder. BCG replaced cystectomy as the treatment of choice for CIS in the mid-1980s. BCG therapy also reduces the risk of recurrence, and ongoing maintenance therapy with BCG reduces the risk of progression in patients with high-grade non–muscle invasive bladder cancer
Treatment/Procedure: BCG Instillation
Conditions Related to BCG Instillation
UAMS Health providers care for a broad range of conditions, some of which may not be listed below.
Locations Providing BCG Instillation
Note that BCG Instillation may not be performed at every location listed below. The list may include locations where the treatment plan is developed during and after a patient visit.
Filter the Locations
![Urology Oncology](https://uamshealth.com/wp-content/uploads/2018/04/urology-oncology-512x288.jpg)
Urology Oncology Clinic
449 Jack Stephens Drive
UAMS Winthrop P. Rockefeller Cancer Institute
Little Rock, AR 72205
- Appointment Phone Numbers
- 501-296-1200
New Patients - 501-686-5655
Returning Patients
Areas of Expertise for BCG Instillation
![Genitourinary Cancers](https://uamshealth.com/wp-content/uploads/2020/10/gu-cancers-512x288.jpg)
Genitourinary Cancer Care (Part of Cancer Care)
The Winthrop P. Rockefeller Cancer Institute takes a team approach to treating genitourinary cancers.